Company Name, Ticker, Customers, else..

Immunic Inc (NASDAQ: IMUX)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Immunic Inc 's

Name: Immunic Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

IMUX Sales vs. its Competitors Q1 2026

Comparing the current results to its competitors, Immunic Inc reported Revenue decrease in the 1 quarter 2026 year on year by 0 %, slower than the combined decrease of the IMUX's competitors by -90.6 %, recorded in the same quarter.

• List of IMUX Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Immunic Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<< IMUX Stock Performance Comparisons

<< See the full list of IMUX competitors

*Market share is calculated based on total revenue.

IMUX's Stock Performance relative to its Competitors

Publicly Traded Peers of Immunic Inc

Equillium Inc
Share Performance

-20.43%

This Quarter

Equillium Inc

Profile

Equillium Inc operates on a business model that focuses on developing and commercializing novel treatments for immune and inflammatory disorders by leveraging their expertise in immunology and translational science. They aim to address unmet medical needs through the discovery and development of therapies targeting specific immune pathways.

More about Equillium Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 248.209 mill.	$ - mill.	$ -40.407 mill.

Serina Therapeutics Inc
Share Performance

-49.05%

One Year

Serina Therapeutics Inc

Profile

The company develops POZ polymer-based drug candidates targeting neurological diseases, including Parkinson's disease.

More about Serina Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 44.076 mill.	$ - mill.	$ -21.185 mill.

X4 Pharmaceuticals Inc
Share Performance

0.00%

This Quarter

X4 Pharmaceuticals Inc

Profile

X4 Pharmaceuticals Inc is a biopharmaceutical company focused on the research and development of innovative treatments for rare diseases, particularly those involving the immune system and rare genetic disorders. Their business model revolves around identifying potential drug candidates, conducting preclinical and clinical trials, and ultimately bringing these therapies to market to improve patient outcomes.

More about X4 Pharmaceuticals Inc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 510.206 mill.	$ 9.014 mill.	$ -99.722 mill.

Sources: Immunic Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Thursday, September 3, 2026 11:44 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Immunic Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.